Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

  1. The aim of RGCC and our cancer blood tests is to detect, analyze and examine cancer cells early at every stage of the disease. As medical research and technology continues to advance, the cancer blood test and other RGCC tests offer promising opportunities for early cancer detection and treatment.

  2. The most comprehensive test is the "Onconomics Plus" test. This provides information on the sensitivity or resistance of the patient's tumour cells to certain cancer drugs and shows options for targeted therapy or an alternative treatment method with organic substances.

  3. RGCC Tests. New methods and reliable tests to facilitate a personalized treatment. Show all RGCC Tests. Onco-D-clare. Onco-D-Clare is an early cancer detection test based on the synergy of molecular biology and artificial neural networks. Show test. InVyomma Plus.

  4. Ο Οδηγός Ασθενών για το Ηπατοκυτταρικό Καρκίνωμα της ΕSMO-Hepatocellular Carcinoma-A Guide for Patients, σχεδιάστηκε, συντάχθηκε και αναθεωρήθηκε από κορυφαίους ειδικούς της νόσου και πιο συγκεκριμένα από μέλη ...

  5. The Athens Comprehensive Cancer Center-ACCC aims to position itself as the first comprehensive cancer center in Greece based on innovative strategies for precision oncology.

  6. Working from our world-leading laboratories in Europe we develop and provide personalised genetic cancer tests for doctors and patients. Our team of scientists and medical experts carry out accurate, reliable genetic tests to discover, analyse and screen cancer cells at every step of the disease.

  7. 6 Απρ 2021 · Hepatocellular carcinomas are the most common primary neoplasia of the liver. The global distribution of hepatocellular carcinoma is related to the prevalence of hepatitis C in the population. Other major etiologic factors include alcoholic liver disease and nonalcoholic steatohepatitis.

  1. Γίνεται επίσης αναζήτηση για